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Interphotoreceptor retinoid-binding protein (IRBP) 
is an extracellular protein that has been suggested to 
participate in the visual process as a carrier for visual 
retinoids. A chimeric gene composed of the human 
IRBP promoter fused to the bacterial reporter gene 
chloramphenicol acetyltransferase (CAT) was used to 
generate transgenic mice. Analysis of six transgenic 
families revealed that the CAT gene, concomitant with 
the endogenous IRBP gene, was expressed primarily 
in the retina and, to a lesser extent, in the pineal gland. 
These results establish that a 1.3-kilobase fragment 
from the 5' end of the human IRBP gene is sufficient 
to direct transgene expression to a visual subdivision 
of the central nervous system. 
IRBP' is a fatty acid-conjugated glycoprotein (1) that is 
expressed at high levels in vertebrate retinal photoreceptor 
cells (2) and, to a lesser degree, in pinealocytes (3). In the 
retina, IRBP is synthesized by the photoreceptor cells and 
secreted into the interphotoreceptor matrix where it binds 
retinoids. IRBP has thus been suggested to playa role in the 
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visual process (reviewed in Refs. 4 and 5). In the developing 
mouse retina, IRBP is expressed when inner segments of the 
photoreceptors start to differentiate (6). Expression of IRBP 
is greatly reduced and its secretion impaired in mice with an 
inherited retinal degeneration (rd) (7). IRBP may also be 
reduced in humans with an autosomal dominant form of 
retinitis pigmentosa (8). Our long range goals are to under-
stand how the IRBP gene is regulated during retinal devel-
opment and in differentiated photoreceptor cells, and how 
retinal degenerations may be related to IRBP gene expression. 
As a first step toward these goals, we report here the use of 
gene transfer experiments in mice to identify a transcriptional 
regulatory region of the human IRBP gene. 
EXPERIMENTAL PROCEDURES 
Materials-The plasmid pTZCAT, MCAT, an extract of cultured 
embryonic chick primary myoblasts transfected with a CAT gene 
promoted by a chicken skeletal muscle actin gene promoter, and (3-
actin gene were gifts from K. L. Chow and Dr. R. J. Schwartz 
(Department of Cell Biology, Baylor College of Medicine). ['·e] 
Chloramphenicol (57 mCi/mmol) was obtained from Amersham In-
ternational. Acetyl coenzyme A (lithium salt) was obtained from 
Pharmacia LKB Biotechnology Inc. Calf intestine alkaline phospha· 
tase was from Boehringer Mannheim. Restriction enzymes, linkers, 
and RNA sizing standard (RNA Ladder) were from Bethesda Re-
search Laboratories. Dye reagent used for protein assay and the 
nucleic acid blotting membranes (Zeta-Probe) were obtained from 
Bio-Rad. 
Plasmid Construction-The 5' -flanking fragment of human IRBP 
gene S3 (9) was digetsed with Pvull and the generated fragment of 
1329 bp was ligated to HindIII linkers. This was then ligated to the 
5' end of a CAT gene (10) contained in the promoterless plasmid 
pTZCAT (11) to form pTZ-IRBPCAT. 
Generation of Transgenic Mice-The procedure used to generate 
transgenic mice2 in this study have been described (12). Single-cell 
stage FVB/N embryos were injected with the BstUI fragment (Fig. 
2) of IRBP-CAT at a concentration of 1 Itg/ml in 10 mM Tris, 0.1 
mM EDT A, pH S.O. Transgenic mice were identified by isolation of 
tail DNA followed by dot blot and/or Southern hybridization to 3~p_ 
labeled IRBP-CAT construct. A total of 250 FVBjN embryos were 
injected, yielding 40 newborns, 6 of which were transgenic.3 All six F 0 
mice were mated to C57BL/6J mice to generage F, offspring. FVBj 
N mice have a recessive mutation at the rd locus. C57BL/6J mice 
and C57BL/6J X FVB/N FI hybrids have normal retinas. 
CA T Assays-CAT activities were assayed essentially according to 
Grichnik et al. (ll), and the procedures are described as follows. 
Tissues were homogenized at 4 "C in Tris-HCI buffer (0.25 M, pH 
7.8) with an OMNI Tissuemizer, heated to 65 "C for 6 min to inactive 
endogenous acetylases (12), and spun in a refrigerated microcentri-
fuge for 10 min at 15,000 rpm. The supernatants were assayed for 
CAT activity by incubation for 90 min at 37"C with 0.5 ItCi of [14C] 
chloramphenicol (50-60 mCi/mmol, Amersham Corp.) and 0.5 mM 
acetyl-CoA (Pharmacia) in 0.25 M Tris-HCl buffer, pH 7.8. At 45 
min, additional acetyl-CoA was added to make its final concentration 
1 mM. Assays were stopped by extraction with ethyl acetate and were 
analyzed by ascending thin-layer chromatography (Kodak chroma-
gram sheet) in chloroform:methanol (95:5) followed by autoradiog-
raphy. Protein concentrations were determined with a dye-reagent 
(Bio-Rad). 
Northern Blot Analysis-Hybridizations were at 42"C in 50% 
2 All animals used were handled in accordance with the guidelines 
established by the Animal Protocol Review Committee at Baylor 
College of Medicine. 
3 The six families have been named 101 to 106 with full designation 
as: Tg (hg-IRBP, CAT, SV40) OVE101-0VE106. 
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formamide and 1 x BLOTTO (13) (0.36 M NaCI, 20 mM sodium 
phosphate, 2 mM EDTA, 2% sodium dodecyl sulfate, and 0.5% nonfat 
dry milk, pH 7.7). Final washes were in 0.5 X SSC (75 mM NaCI, 7.5 
mM sodium citrate, pH 7.0) at 65 "C. Hybridization membranes were 
exposed to XAR-5 film (Kodak) with intensification screens at 
-80 "C. 
RESULTS AND DISCUSSION 
The structure of the human IRBP gene and its 5' -flanking 
region, IRBP-S3, was reported previously (9). As observed for 
many other eucaryotic genes (14), this fragment lacks TATA 
and CAAT boxes within conventional distances upstream of 
the transcription start site (9), and the putative promoter 
region appears to be GC-rich. To identify sequences in the 
IRBP-S3 that regulate transcription and confer tissue speci-
ficity, we chose a 1329-bp PuuII fragment overlapping the 
transcription start site (Fig. 1) to be linked to the coding 
sequences of the bacterial CAT gene (Fig. 2). Transgenic mice 
were generated by microinjection of the fusion gene into one-

























FIG. 1. Nucleotide sequence of the Pvull fragment of IRBP-
83, the 5' -flanking region of the human IRBP gene. Numbers 
on the right indicate nucleotide positions starting with the transcrip-
tion start site as position 1. 
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FIG. 2. Human IRBP gene and construction of the IRBP-
CAT fusion gene. A, the distribution of exons (boxes), introns 
(lines), and flanking regions of the human IRBP gene (9). The hatched 
boxes represent the protein coding regions. B, IRBP-CAT fusion gene. 
A 1329-bp Pvull fragment containing IRBP sequences from -1311 
to + 19 bp was fused with HindlII linkers to the 5' end of a CAT gene 
(10) in the promoterless CAT plasmid pTZCAT (11). The CAT gene 
(1625 bp) consists of the CAT coding and noncoding sequences, an 
SV40 fragment containing the small t-antigen intron (stippled box), 
and an SV 40 fragment containing the early region polyadenylation 
site (box with vertical lines) (10). The 3407-bp BstUI restriction 
fragment was used for micro injections. 
TABLE I 
The copy number, transmission rate, and CA T activity in the 
transgenic mouse families 
Copy numbers in F, animals were determined by dot blot hybridi-
zation to :l2P-Iabeled IRBP-CAT construct and scintillation counting 
of positive dots. Copy number per haploid genome was estimated by 
comparison to standards containing known amounts of IRBP-CAT 
DNA mixed with nontransgenic mouse DNA. Percent transmission 
was determined by screening the offspring of Fox wild type matings 
by means of dot blot and/or Southern hybridizations to tail DNA. 
CAT activities were assayed as described (11), except that the incu-
bation time was 30 min and the amount of soluble protein per assay 
was adjusted to ensure a linear range of acetylation (40% or lower). 
Radioactive spots were excised and counted. One unit of CAT activity 
was defined as the amount of enzymatic activity catalyzing acetyla-
tion of 1 I"mol of chloramphenicol/min at 37 "C (16). PECS, retinal 
pigment epithelium accompanied by choroid and sclera. NT, not 
tested. 
Transmission CAT activity 
Copy Family 
number Per- Number Neuro- Cere-
cent screened retina PECS Pineal brum 
milliunits/mg protein 
101 30 53 19 1350 33 NT 0.2 
102 3 35 17 4 0.3 NT <0.01 
103 20 53 53 674 25 NT 0.04 
104 5 22 9 700 17 75 <0.01 
105 100 22 32 200 93 14 NT 
106 30 14 37 933 14 103 <0.01 
founder (Fo) animals, five females and one male, were iden-
tified by Southern hybridization (data not shown). Two ofthe 
Fo mice transmitted the IRBP-CAT sequences to approxi-
mately 50% of their offspring. The remaining four Fo mice 
had lower transmission rates (14 to 35%), suggesting that 
these mice were mosaic. The copy numbers of the integrated 
DNA ranged from 3 to about 100 in the FJ mice (Table I). 
F I mice from all six families were screened to determine 
the tissue specificity of the IRBP·CAT gene expression (Fig. 
3). Retinas were separated into two components, the neuro-
retina, and retinal pigment epithelium (PE) accompanied by 
choroid-sclera (PECS). The retinal PE cells and photorecep-
tor outer segments interdigitate (15) rendering their quanti· 
tative separation difficult. In all six families, high levels of 
CAT activity were present in both neuro-retina and PECS. 
Much lower activities were detected in the brains (Fig. 3A). 
In order to evaluate the pattern of CAT activity in the brain, 
cerebrum, cerebellum, and pineal gland of three families were 
dissected. CAT activity was found in the pineal glands of all 
three families (Fig. 3B). Very little CAT activity was found 
in the cerebellum or cerebral cortex in these families. CAT 
activity was not detected in other tissues (Fig. 3C). These 
results indicate that the human IRBP promoter functions 
appropriately in transgenic mice and directs gene expression 
specifically to the mouse tissues that contain endogenous 
IRBP. 
To compare the levels of CAT activity in neuro-retina, 
PECS, pineal gland, and cerebrum, quantitative enzyme as-
says were done on one FJ mouse in each family (Table I). The 
neuro-retinas showed the highest levels of CAT activity in all 
six families. Purified CAT enzyme from Escherichia coli has 
a specific activity of about 100 units/mg (16). Assuming that 
the intrinsic activity of the enzyme is unmodified in the retina, 
the specific activity of 1.3 units/mg in the retina of family 
101 indicates that the CAT protein constitutes about 1% of 
the soluble protein in the retina. CAT activities measured in 
the pineal glands of the three families tested were around 10% 
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FIG. 3. CAT activities. Various tis-
sues ofF, mice were assayed as described 
earlier (11). Assay conditions for the ret-
inal tissues are nonlinear. Five Ilg of 
soluble protein were used in each assay, 
except for pineal, for which only 1.5 Ilg 
of protein was available. The unacety-
lated (Cm), monoacetylated (Cm-I-Ac 
and Cm-3-Ac), and diacetylated (Cm-
I ,3-Ac) forms of chloramphenicol are 
shown for family 106. Only the mono 
and diacetylated forms of chloramphen-
icol are shown for the other families. 
PECS, retinal pigment epithelium ac-
companied by choroid and sclera. A, 
CAT activities in a variety of tissues for 
the six families. In these assays whole 
brain homogenates were used. Neg-Ret-
ina, retinas from a non transgenic litter-
mate. MCA T, an ext ract of cultured em-
bryonic chick primary myoblasts trans-
fected with a CAT gene promoted by a 
chicken skeletal muscle actin gene pro-
moter (a gift from K. L. Chow). B, CAT 
activities in the ocular and brain tissues 
..,.' ¢' ..; 
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of families 104, 105, and 106. In these 
families the pineal gland, cerebral cortex, 
and cerebellum were isolated by dissec-
tion. C, CAT assays were repeated on 
family 106 to include other tissues that 
were not assayed in A or B. Neg-Eye and 
Neg-Liver, tissue homogenates from a 
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of the activities in the neuro-retinas. CAT activities in the 
cerebral cortexes were near background levels_ 
IRBP-CAT expression in the pineal gland is not surprising. 
It is generally accepted that a major population of mammalian 
pineaolocytes evolved from pineal photoreceptor cells, which 
are photosensitive in lower vertebrates (17)_ During evolution, 
these pineal photoreceptor cells appear to have been progres-
sively transformed into endocrine secretory cells. However, 
mammalian pinealocytes and retinal photo receptors still 
share a number of common proteins, including IRBP, S-
antigen, or 48-kDa protein, rhodopsin kinase, and opsin (re-
viewed in Ref. 3). It is thought that in higher vertebrates the 
pineal gland may play a role in the regulation of circadian 
rhythms (18). 
The presence of CAT activity in the PECS was unexpected, 
since the endogenous IRBP gene is expressed specifically in 
the photoreceptor cells of the neuro-retina (2)_ To determine 
whether the IRBP-CAT gene is transcribed in both neuro-
retina and retinal PECS, poly(A·) RNAs were isolated from 
these tissues of an F\ mouse of family 101 and analyzed by 
Northern hybridization (Fig. 4A). Transcripts encoding IRBP 
(5.7 kb, Ref_ 5), opsin (transcripts of 1.75- 4_9 kb, Ref. 19) 
(data not shown) and the CAT transgene (1.9 kb) were de-
tected exclusively in the neuroretina. Overexposure of the 
autoradiograph shown in Fig. 3A failed to show any trace of 
a CAT transcript in the PECS (data not shown). The CAT 
- Call-At 
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activity that is detected in the PECS may therefore be the 
consequence of the normal phagocytosis of photoreceptor 
outer segments by the retinal PE cells (15). Alternatively, the 
CAT activity in the PECS may be attributed to incomplete 
separation of PECS from photoreceptor outer segments which 
may contain significant amounts of CAT enzyme. 
To determine whether the integration of the IRBP-CAT 
construct altered the endogenous IRBP transcription, retinal 
poly(A +) RNAs from Fl mice of family 101 and family 105 
were analyzed. Both families have high copy numbers of the 
transgenic DNA (3D and 100 copies per haploid genome, 
respectively) (Table I)_ The endogenous 5.7-kb IRBP mRNA 
was present at similar levels in transgenic and nontransgenic 
mice as judged by comparison with the expression of the f3-
actin gene (20) (Fig. 4B)_ In addition, electroretinogram pat-
terns in representative transgenic mice appear to be normal, 
an indication of normal retinal function (data not shown). 
These studies using transgenic mice demonstrate that a 
1.3-kb fragment from the 5' end of the human IRBP gene is 
sufficient to promote tissue-specific gene expression in vivo. 
The promoter is active in the neuro-retina and the pineal 
gland. Based on the pattern of expression of the endogenous 
IRBP gene, it is likely that the IRBP promoter is active 
specifically in the photoreceptor cells within the neuro-retina. 
To our knowledge, this is the first demonstration of a pro-
moter that can direct transgene expression to the visual 
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FIG. 4. Northern analysis of poly(A +) RN As. Isolations of 
mouse neuro·retina and PECS poly(A"') RNA were carried out ac-
cording to the method described by Badley et al. (21); bovine and 
human neuro-retina poly(A·) RNA was isolated as described by 
Chirgwin et al. (22) . RNA samples of 2 jig were separated on formal-
dehyde denaturing gels and then blotted to Zeta-Probe. Hybridiza-
tions and post-hybridization washes were carried out as described 
previously (13) . Hybridization probes are indicated on the left: Mouse 
IRBP, a 722-bp mouse IRBP eDNA, corresponding to human IRBP 
cDNA positions 3089 to 3810 (G. I. LiDU, unpublished results); CAT, 
the IRBP-CAT construct; and (3-ACTlN, the chicken cytoplasmic (3-
actin eDNA (20). A, neuro·Retina (lane 1) and PECS (lane 2) 
poly(A"') RNAs from a transgenic F, mouse of family 101. B, neuro-
retina poly(A'") RNAs from transgenic families 101 and 105; lanes 1 
and 3, transgenic mice; lanes 2 and 4, nontransgenic littermates. The 
sizes of the hybridizing transcripts (in kilobases) were estimated by 
comparison to an RNA ladder. The CAT transcript is about 1.9 kb 
in size and may have a large poly(A+) tail attached to the 1.5·kb 
predicted transcript, since neither a 600-bp IRBP promoter fragment 
upstream of the cap site nor a 400-bp fragment downstream of t.he 
polyadenylation site showed hybridization to the CAT transcript 
(data not shown). The bovine and human IRBP transcripts are the 
expected sizes of 6.5 kb (23) and 4.4 kb (5), respectively. 
subdivision of the nervous system. The identification of this 
retina/pineal-specific promoter represents a significant ad-
vance for studies of IRBP gene regulation, retinoblastoma 
formation, and retinal degeneration. In addition, the promoter 
potentially provides a valuable tool for future transgenic 
studies of photoreceptor cell development, differentiation, and 
function. 
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